Related to Breast Cancer Suppressing Enzyme Could Reverse Obesity

• University of Florida Receives $15M, and Berkeley Lab Obtains $12.8M in ARRA Funding
  
• Roche to Plug Over $181M Into Manufacturing Sites to Produce Self-Administration Device for Herceptin
  
• Merck & Co. Taps Envoy for Target Discovery in Diabetes and Obesity
  
• Jubilant and Endo Broaden Oncology Drug Discovery Partnership
  
• Investigators Identify Gene with Prognostic Value for Breast Cancer
  
• TGen Gains Open Access to Horizon’s Gene-Engineering and Isogenic Cancer Cell Line Platform
  
• AstraZeneca Teams Up with CRT to Develop Drugs that Target Cancer Cell Metabolism
  
• DxS Negotiates PI3K License from JHU to Develop Companion Diagnostics
  
• Curis Earns $8M Milestone from Debiopharm on French Clearance of Hsp90 Inhibitor Trial
  
• Investigators Find that SRC-3 Enables Breast Cancer Invasion
  
• Horizon and University of Torino Win $500K Grant to Develop SNP-Based Cancer Models
  
• Scientists Find Protein that Prevents Cancer-Related Telomerase Activity
  
• Researchers Provide New Evidence for Role of FGFR1 Amplification in Tamoxifen Resistance
  
• Astellas Bids $3.5B on OSI for Cancer Focus
  
• PolyTherics and Zealand Ink PEGylated Peptide Therapeutics Collaboration
  
• Life Technologies, The Translation Genomics Research Institute, and US Oncology to Conduct Breast Cancer Sequencing Project
  
• Evotec to Screen for Hits against Active Biotech Immune Disorder and Cancer Target
  
• Pfizer Quashes Three More Phase III Cancer Trials
  
• FDA Not Ready to Approve A.P. Pharma’s Treatment for Chemotherapy-Induced Nausea and Vomiting
  
• Scientists Identify Gene Abnormality that Is Predictive of Breast Cancer Response to Anthracyclines